C. Grison et al. / Tetrahedron 58 02002) 2735±2741
2739
84.1, 83.6, 69.2, 68.0, 54.8, 39.7, 26.3, 24.9, 21.5; MS
FAB1: m/z 305 2MH1, 15%), 273 2100), 231 238).
TLC 2hexane/AcOEt 22/1)) Rf 0.66; IR n 2cm21): 2108,
1738. 1H NMR 2250 MHz, CDCl3): d5.48 21H, d,
J5.1 Hz, H1), 5.16±5.02 21H, m, COOCH2Me)2), 4.61
21H, dd, J2.6, 8.1 Hz, H3), 4.30 21H, dd, J5.1, 2.6 Hz,
H2), 4.14 21H, dd, J8.1, 1.7 Hz, H4), 4.06 21H, dd, J6.0,
8.1 Hz, CHCOO), 3.93 21H, ddd, J1.7, 9.0, 4.7 Hz, H5),
2.26±1.97 22H, m, CH2), 1.52 23H, s, CH3), 1.46 23H, s,
CH3), 1.35 23H, s, CH3), 1.32 2s, 3H, CH3), 1.30 23H, d,
J6.4 Hz, COOCH2CH3)2), 1.29 23H, d, J6.4 Hz,
COOCH2CH3)2). 13C NMR d: 169.4, 109.4, 108.7, 96.3,
72.4, 70.9, 70.4, 69.7, 64.3, 58.9, 31.8, 26.0, 25.8, 24.9,
24.5, 21.7, 21.6.
Compound 20b. TLC 2hexane/AcOEt 22/1)) Rf 0.4; IR n
2cm21): 3473, 1736. 1H NMR 2250 MHz, CDCl3):
d5.16±5.06 21H, m, COOCH2Me)2), 4.97 21H, s, H1),
4.69±4.61 22H, m, H2, H3), 4.40 21H, t, J7.3 Hz, H4),
4.27 21H, dd, J5.1, 7.3 Hz, CHCOO), 3.36 23H, s,
OCH3), 3.07 21H, br s, OH), 2.11±1.90 22H, m, CH2),
1.48 23H, s, CH3), 1.32 23H, s, CH3), 1.29 26H, d,
J6.0 Hz, COOCH2CH3)2). 13C NMR d: 173.8, 112.2,
109.5, 85.2, 84.1, 83.7, 69.4, 68.3, 54.8, 39.1, 26.3, 24.8,
21.4; MS FAB1: m/z 305 2MH1, 15%), 289 215), 273 2100),
231 238).
4.3.2. Isopropyl 7-azido-6,7-dideoxy-1,2:3,4-di-O-isopro-
pylidene-d-glycero-a-d-galacto-octopyranuronate 30a.
TLC 2hexane/AcOEt 22/1)) Rf 0.71; IR n 2cm21): 2115,
1738. 1H NMR 2250 MHz, CDCl3): d5.52 21H, d,
J5.1 Hz, H1), 5.17±5.02 21H, m, COOCH2Me)2), 4.63
21H, dd, J2.6, 8.1 Hz, H3), 4.33 21H, dd, J5.1, 2.6 Hz,
H2), 4.17 21H, dd, J3.0, 11.5 Hz, CHCOO), 4.12 21H, dd,
J8.1, 1.7 Hz, H4), 4.03±3.97 21H, m, H5), 2.27±2.15 21H,
m, CH2), 1.75±1.63 21H, m, CH2), 1.58 23H, s, CH3), 1.47
23H, s, CH3), 1.35 26H, s, CH3), 1.30 23H, d, J6.4 Hz,
COOCH2CH3)2), 1.29 23H, d, J6.4 Hz, COOCH2CH3)2).
13C NMR d: 170.0, 109.3, 108.7, 96.3, 72.9, 70.9,
70.6, 69.6, 63.8, 59.2, 32.0, 25.9, 25.6, 25.0, 24.2, 21.7,
21.6.
4.2.4. Isopropyl 5-deoxy-1-O-methyl-2,3-O-isopropyl-
idene-d,l-glycero-a-d-lyxo-heptofuranuronate 2c/20c.
Compound 2c. TLC 2hexane/AcOEt 22/1)) Rf 0.35; IR n
2cm21): 3451, 1731. 1H NMR 2250 MHz, CDCl3):
d5.15±5.05 21H, m, COOCH2Me)2), 4.79 21H, s, H1),
4.65 21H, dd, J3.9, 6.0 Hz, H3), 4.54 21H, d, J6.0 Hz,
H2), 4.36±4.30 21H, m, CHCOO), 4.20±4.11 21H, m, H4),
3.27 23H, s, OCH3), 3.16 21H, d, J3.8 Hz, OH), 2.22±2.17
22H, m, CH2), 1.45 23H, s, CH3), 1.32 23H, s, CH3), 1.29
23H, d, J6.4 Hz, COOCH2CH3)2), 1.28 23H, d, J6.4 Hz,
COOCH2CH3)2). 13C NMR d: 174.2, 112.3, 106.6, 85.0,
80.6, 75.3, 69.3, 67.9, 54.2, 32.6, 26.0, 25.0, 21.6, 21.4;
MS FAB1: m/z 305 2MH1, 35%), 289 231), 273 2100),
231 285).
4.3.3. Isopropyl 6-azido-5,6-dideoxy-1-O-methyl-2,3-O-
isopropylidene-d,l-glycero-b-d-ribo-heptofuranuronate
3b/30b. Compound 3b. TLC 2hexane/AcOEt 22/1)) Rf 0.74;
Compound 20c. TLC 2hexane/AcOEt 22/1)) Rf 0.35; IR n
2cm21): 3451, 1731. 1H NMR 2250 MHz, CDCl3): d5.16±
5.06 21H, m, COOCH2Me)2), 4.89 21H, s, H1), 4.65 21H, dd,
J3.4, 6.0 Hz, H3), 4.54 21H, d, J6.0 Hz, H2), 4.39±4.31
21H, m, CHCOO), 4.21±4.15 21H, m, H4), 3.34 23H, s,
OCH3), 3.04 21H, d, J7.2 Hz, OH), 2.32±2.19 21H, m,
CH2), 2.01±1.90 21H, m, CH2), 1.48 23H, s, CH3), 1.33
23H, s, CH3), 1.29 23H, d, J6.4 Hz, COOCH2CH3)2),
1.28 23H, d, J6.4 Hz, COOCH2CH3)2). 13C NMR d:
174.2, 112.3, 106.6, 85.0, 80.6, 76.2, 69.2, 68.4, 54.2,
33.2, 25.9, 24.8, 21.6, 21.4; MS FAB1: m/z 305 2MH1,
35%), 289 231), 273 2100), 231 285).
1
IR n 2cm21): 2109, 1738. H NMR 2250 MHz, CDCl3):
d5.17±5.05 21H, m, COOCH2Me)2), 4.97 21H, s, H1),
4.63 21H, d, J6.0 Hz, H2), 4.59 21H, d, J6.0 Hz, H3),
4.30 21H, dd, J6.4, 8.5 Hz, H4), 3.97 21H, t, J7.3 Hz,
CHCOO), 3.36 23H, s, OCH3), 2.18±1.93 22H, m, CH2),
1.49 23H, s, CH3), 1.33 23H, s, CH3), 1.32 23H, d,
J6.0 Hz, COOCH2CH3)2), 1.31 23H, d, J6.0 Hz,
COOCH2CH3)2). 13C NMR d: 169.3, 112.5, 109.8, 85.2,
83.8, 83.6, 70.0, 59.3, 55.1, 36.4, 26.3, 24.9, 21.6.
Compound 30b. TLC 2hexane/AcOEt 22/1)) Rf 0.70; IR n
2cm21): 2112, 1739. 1H NMR 2250 MHz, CDCl3): d5.16±
5.01 21H, m, COOCH2Me)2), 4.98 21H, s, H1), 4.63 21H, d,
J5.6 Hz, H2), 4.57 21H, d, J5.6 Hz, H3), 4.36 21H, dd,
J3.4, 11.5 Hz, H4), 4.08 21H, dd, J3.0, 11.5 Hz,
CHCOO), 3.37 23H, s, OCH3), 2.14±2.03 21H, m, CH2),
1.84±1.72 21H, m, CH2), 1.49 23H, s, CH3), 1.32 23H, s,
CH3), 1.29 23H, d, J6.4 Hz, COOCH2CH3)2), 1.28 23H,
d, J6.4 Hz, COOCH2CH3)2). 13C NMR d: 169.9, 112.4,
109.8, 85.3, 83.9, 83.2, 69.7, 59.5, 55.2, 36.6, 26.3, 24.9,
21.6.
4.3. Preparation of the azido compounds 3/30
Typical procedure. A mixture of 1 equiv. of a-hydroxyester
2a/20a 295/5) 20.21 g, 0.58 mmol) and 4 equiv. of pyridine
20.18 g, 2.3 mmol) in 15 ml of dichloromethane was added
dropwise at 08C to a solution of 1.4 equiv. of tri¯uoro-
methane sulfonic anhydride 20.23 g, 0.82 mmol) diluted in
2 ml of dichloromethane. The mixture was stirred for 5 min,
then 50 equiv. of sodium azide 21.9 g, 29 mmol) and 20 ml
of dimethylformamide were added. The mixture was stirred
for 16 h, and then concentrated under reduced pressure
before 10 ml of water was added. The aqueous layer was
extracted with dichloromethane, the organic phase was dried
on magnesium sulfate, ®ltered, and evaporated. Toluene was
added, and evaporated again. The crude product was then
puri®ed on a silica gel chromatographic column to give
0.135 g 260%) of a colourless oil of 3a/30a 25/95).
4.3.4. Isopropyl 6-azido-5,6-dideoxy-1-O-methyl-2,3-O-
isopropylidene-d,l-glycero-a-d-lyxo-heptofuranuronate
3c/30c. Compound 3c. TLC 2hexane/AcOEt 22/1)) Rf 0.74;
1
IR n 2cm21): 2112, 1739. H NMR 2250 MHz, CDCl3):
d5.18±5.03 21H, m, COOCH2Me)2), 4.88 21H, s, H1),
4.65 21H, dd, J3.4, 6.0 Hz, H3), 4.58 21H, d, J6.0 Hz,
H2), 4.13±4.05 22H, m, CHCOO, H4), 3.33 23H, s, OCH3),
2.34±2.22 21H, m, CH2), 2.05±1.92 21H, m, CH2), 1.47 23H,
s, CH3), 1.32 23H, s, CH3), 1.31 23H, d, J6.4 Hz,
COOCH2CH3)2), 1.30 23H, d, J6.4 Hz, COOCH2CH3)2).
4.3.1. Isopropyl 7-azido-6,7-dideoxy-1,2:3,4-di-O-isopro-
pylidene-l-glycero-a-d-galacto-octopyranuronate
3a.